Rakuten Medical announces promising interim results from photoimmunotherapy study at ASCO 2024

Rakuten Medical, Inc., a pioneer in biotechnology focusing on precision, cell-targeting photoimmunotherapy, unveiled updated interim results from its Phase 1b/2 study of ASP-1929 photoimmunotherapy in ... Read More